Invesco’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Invesco’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-976,873	Closed	-$8.76M	–	3789
2016 Q3	$8.76M	Buy	+976,873	New	+$6.95M	﹤0.01%	1586
2015 Q3	–	Sell	-348	Closed	-$5K	–	4322
2015 Q2	$5K	Buy	+348	New	+$4.23K	﹤0.01%	4274
2013 Q4	–	Sell	-89,406	Closed	-$1.33M	–	4477
2013 Q3	$1.33M	Buy	+89,406	New	+$1.07M	﹤0.01%	2833

Invesco's RPTP Position: Q4 2016 in Review

Invesco sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 976,873 shares — an estimated $8.76M sold.

Invesco first reported a position in RPTP in Q3 2013 and held it in 3 quarters. The position peaked at $8.76M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Invesco reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Invesco sold 976,873 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $8.76M.
Invesco first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 3 quarters.
Invesco's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $8.76M in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Invesco's 13F filing for Q4 2016, filed 14 Feb 2017.